MiR-139-5p is a causal biomarker for type 2 diabetes; Results from genome-wide microRNA profiling and Mendelian randomization analysis in a population-based study
View ORCID ProfileMichelle M.J. Mens, Rima Mustafa, Fariba Ahmadizar, M. Arfan Ikram, Marina Evangelou, Maryam Kavousi, View ORCID ProfileAbbas Dehghan, View ORCID ProfileMohsen Ghanbari
doi: https://doi.org/10.1101/2021.05.13.21257090
Michelle M.J. Mens
1Department of Epidemiology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands
2Department of Child and Adolescent Psychiatry/Psychology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands
Rima Mustafa
3Department of Epidemiology and Biostatistics, Imperial College London, London, United Kingdom
Fariba Ahmadizar
1Department of Epidemiology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands
M. Arfan Ikram
1Department of Epidemiology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands
Marina Evangelou
4Department of Mathematics, Imperial College London, London, United Kingdom
Maryam Kavousi
1Department of Epidemiology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands
Abbas Dehghan
3Department of Epidemiology and Biostatistics, Imperial College London, London, United Kingdom
5MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, Norfolk Place, London, UK
6UK Dementia Research Institute at Imperial College London, Burlington Danes Building, Hammersmith Hospital, DuCane Road, London W12 0NN UK
Mohsen Ghanbari
1Department of Epidemiology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands
Posted May 17, 2021.
MiR-139-5p is a causal biomarker for type 2 diabetes; Results from genome-wide microRNA profiling and Mendelian randomization analysis in a population-based study
Michelle M.J. Mens, Rima Mustafa, Fariba Ahmadizar, M. Arfan Ikram, Marina Evangelou, Maryam Kavousi, Abbas Dehghan, Mohsen Ghanbari
medRxiv 2021.05.13.21257090; doi: https://doi.org/10.1101/2021.05.13.21257090
MiR-139-5p is a causal biomarker for type 2 diabetes; Results from genome-wide microRNA profiling and Mendelian randomization analysis in a population-based study
Michelle M.J. Mens, Rima Mustafa, Fariba Ahmadizar, M. Arfan Ikram, Marina Evangelou, Maryam Kavousi, Abbas Dehghan, Mohsen Ghanbari
medRxiv 2021.05.13.21257090; doi: https://doi.org/10.1101/2021.05.13.21257090
Subject Area
Subject Areas
- Addiction Medicine (313)
- Allergy and Immunology (616)
- Anesthesia (158)
- Cardiovascular Medicine (2257)
- Dermatology (201)
- Emergency Medicine (368)
- Epidemiology (11550)
- Forensic Medicine (10)
- Gastroenterology (676)
- Genetic and Genomic Medicine (3542)
- Geriatric Medicine (336)
- Health Economics (612)
- Health Informatics (2287)
- Health Policy (910)
- Hematology (333)
- HIV/AIDS (742)
- Medical Education (357)
- Medical Ethics (100)
- Nephrology (386)
- Neurology (3327)
- Nursing (190)
- Nutrition (504)
- Oncology (1748)
- Ophthalmology (523)
- Orthopedics (208)
- Otolaryngology (283)
- Pain Medicine (222)
- Palliative Medicine (66)
- Pathology (436)
- Pediatrics (998)
- Primary Care Research (399)
- Public and Global Health (5975)
- Radiology and Imaging (1216)
- Respiratory Medicine (807)
- Rheumatology (367)
- Sports Medicine (311)
- Surgery (383)
- Toxicology (50)
- Transplantation (170)
- Urology (142)